合成和天然的Mortalin抑制剂用于癌症治疗
Shruti Kaushal1, Samriddhi Gupta1, Seyad Shefrin2
1Department of Computational Biology, Indraprastha Institute of Information Technology (IIIT) Delhi, Okhla Industrial Estate, Phase III, New Delhi 110020, India.
Cancers
|October 26, 2024
概括
压力伴侣Mortalin驱动癌症的进展和抵抗力. 针对Mortalin的抑制剂显示为新型抗癌疗法,提供新的治疗途径.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 莫尔塔林 (HSP70) 伴侣上调与细胞恶性转变,瘤发生和癌症进展有关.
- 升高的Mortalin水平与侵袭性瘤阶段,转移,耐药性和癌症复发相关.
- 莫尔塔林关键地支持癌细胞的增殖,迁移,入侵,并抑制细胞亡.
研究的目的:
- 审查Mortalin在瘤发生中的关键作用.
- 讨论新兴的Mortalin抑制剂作为潜在的抗癌药物.
- 为了阐明各种Mortalin抑制剂的抗癌潜力.
主要方法:
- 对Mortalin在癌症中的作用进行的体外和体内研究的综述.
- 分析各种Mortalin抑制剂,包括,小RNA,天然化合物,合成化合物和抗体.
- 对已识别的抑制剂的抗癌性质和作用机制的评估.
主要成果:
- 死亡素上调是多种癌症特征的关键驱动因素.
- 不同类型的Mortalin抑制剂在临床前研究中显示出显著的抗癌活性.
- 抑制剂向Mortalin的亲瘤功能,影响癌细胞存活和增殖.
结论:
- 莫尔塔林是各种癌症的验证治疗点,因为它在瘤发生过程中的多方面的作用.
- 莫尔塔林抑制剂是新型抗癌药物的有希望的类别.
- 对Mortalin向疗法的进一步研究可能会导致改善癌症治疗策略.
相关概念视频
Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


